This report contains the following four sections:
High-level takeaways and implications - This section lays out what the data in this report is telling us and how it could impact your development strategies and operations.
EDC service provider section – This section focuses on how Principal Investigators and Site Coordinators view the various aspects and market dynamics as they relate to Electronic Data Capture. These include:
• Adoption and preference for EDC
• Service provider brand leadership and performance
ePRO service provider section – This section focuses on how Principal Investigators and Site Coordinators view the various aspects and market dynamics as they relate to Electronic Patient Reported Outcomes. These include:
• Adoption and preference for ePRO
• Service provider brand leadership and performance
Trends and ideas impacting clinical development – This section ties together respondents’
Scope of the report:
• How to select a technology partner that enhances your relationships with sites
• Preferences for specific EDC and ePRO applications
• What study types users believe are least suited for the technologies
• Current and future adoption estimates for ePRO
• Which technology providers have the best and worst integration capabilities with other technologies
• Their own brand's strength vs. competing providers
• Product adoption profiles for all major brands
• Detailed performance profiles for all major technology providers across critical success factors
• Competitive strengths and weaknesses
• Product satisfaction profiles across all major brands
• Technology users' brand preferences
For more information and to purchase this Insight Pharma Report, visit: http://www.InsightPharmaReports.com
About Insight Pharma Reports
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace. Insight Pharma Reports is a division within Cambridge Healthtech Institute. http://www.InsightPharmaReports.com
Insight Pharma Reports offers our Affiliated Reports Collection which provides a repository of additional scientific and business resources. For more information, visit http://www.insightpharmareports.com/
# # #
Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets.
Photo:
http://www.prlog.org/




